Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Interest in a Mobile App for Two-Way Risk Communication: A Survey Study Among European Healthcare Professionals and Patients
Sieta T. de Vries, Petra Denig, Carmen Lasheras Ruiz, et al.
Drug Safety (2018) Vol. 41, Iss. 7, pp. 697-712
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Sociotechnical Factors Affecting Patients’ Adoption of Mobile Health Tools: Systematic Literature Review and Narrative Synthesis
Christine Jacob, Emre Sezgın, Antonio Sánchez-Vázquez, et al.
JMIR mhealth and uhealth (2022) Vol. 10, Iss. 5, pp. e36284-e36284
Open Access | Times Cited: 106
Recommendations on the Use of Mobile Applications for the Collection and Communication of Pharmaceutical Product Safety Information: Lessons from IMI WEB-RADR
Carrie E. Pierce, Sieta T. de Vries, Stephanie Bodin-Parssinen, et al.
Drug Safety (2019) Vol. 42, Iss. 4, pp. 477-489
Open Access | Times Cited: 50
Employing bibliometrics and natural language processing (NLP) to analyse real-world applications of adverse drug reaction
Viola Savy Dsouza, Lada Leyens, Angela Brand
Exploratory Research in Clinical and Social Pharmacy (2025), pp. 100592-100592
Open Access
Smartphone-based mobile applications for adverse drug reactions reporting: global status and country experience
Ayako Fukushima, Noha Iessa, Madhava Ram Balakrishnan, et al.
BMC Medical Informatics and Decision Making (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 17
Consumers’ knowledge and experiences of adverse drug reaction reporting in Australia: a national survey
Mohammed Gebre Dedefo, Renly Lim, Gizat M. Kassie, et al.
European Journal of Clinical Pharmacology (2024) Vol. 80, Iss. 10, pp. 1543-1554
Open Access | Times Cited: 3
Use of Health Apps and Wearable Devices: Survey Among Italian Associations for Patient Advocacy
Paola Mosconi, Silvia Radrezza, Emanuele Lettieri, et al.
JMIR mhealth and uhealth (2018) Vol. 7, Iss. 1, pp. e10242-e10242
Open Access | Times Cited: 31
Mobile apps for quick adverse drug reaction report: A scoping review
Edna Ribeiro Parracha, Ana Margarida Advinha, Manuel José Lopes, et al.
Pharmacoepidemiology and Drug Safety (2022) Vol. 32, Iss. 1, pp. 19-27
Open Access | Times Cited: 14
Comparison of Patient Adverse Drug Reaction Reporting Systems in Nine Selected Countries
Wiwan Worakunphanich, Sitaporn Youngkong, Wimon Suwankesawong, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 8, pp. 4447-4447
Open Access | Times Cited: 13
Facilitators and Barriers to Uptake of the Med Safety Mobile App for Adverse Drug Reaction Reporting by Health Workers in Uganda: A Qualitative Study
Ronald Kiguba, Henry Zakumumpa, Helen Byomire Ndagije, et al.
Drug Safety (2023) Vol. 46, Iss. 6, pp. 565-574
Open Access | Times Cited: 7
Mobile Health Apps Preferences and Practice Among Ambulatory Cardiovascular Patients
Rajesh Reddy, Maulik D. Majmudar, Neil Dhopeshwarkar, et al.
Future Cardiology (2018) Vol. 14, Iss. 5, pp. 381-388
Closed Access | Times Cited: 17
Design Considerations in the Development of App-Based Oral Anticancer Medication Management Systems: a Qualitative Evaluation of Pharmacists’ and Patients’ Perspectives
Eskinder Eshetu Ali, Sharlene Si Ling Chan, Huan Yu Poh, et al.
Journal of Medical Systems (2019) Vol. 43, Iss. 3
Closed Access | Times Cited: 17
Gestational diabetes mellitus care re‐imagined – A cost‐minimisation analysis: Cost savings from a tertiary hospital, using a novel, digital‐based gestational diabetes management model
Josephine Laurie, Shelley A. Wilkinson, David McIntyre, et al.
Australian and New Zealand Journal of Obstetrics and Gynaecology (2023) Vol. 63, Iss. 5, pp. 709-713
Open Access | Times Cited: 5
Adverse Drug Reaction Reporting Using a Mobile Device Application by Persons with Multiple Sclerosis: A Cluster Randomized Controlled Trial
Gilles Defer, Sophie Fédrizzi, Damien Chevanne, et al.
Drug Safety (2020) Vol. 44, Iss. 2, pp. 223-233
Closed Access | Times Cited: 11
Patient literacy and awareness of medicine safety
Marissa See, Belinda Butcher, Alex Banh
International Journal of Pharmacy Practice (2020) Vol. 28, Iss. 6, pp. 552-560
Open Access | Times Cited: 10
Adverse drug reaction reporting via mobile applications: A narrative review
Dario Leskur, Joško Božić, Doris Rušić, et al.
International Journal of Medical Informatics (2022) Vol. 168, pp. 104895-104895
Closed Access | Times Cited: 7
Thai stakeholders’ awareness and perceptions of the patient adverse event reporting system for herbal medicines: a qualitative study
Wiwan Worakunphanich, Wimon Suwankesawong, Sitaporn Youngkong, et al.
International Journal of Clinical Pharmacy (2023) Vol. 45, Iss. 2, pp. 491-501
Open Access | Times Cited: 3
First results from the lessons learnt from the deployment of the Med Safety App for reporting adverse drug reactions in Ghana
Seth Kwaku Seaneke, Delese Mimi Darko, Edwin Nkansah, et al.
Digital Health (2023) Vol. 9
Open Access | Times Cited: 3
Workshop on the Italian Pharmacovigilance System in the International Context: Critical Issues and Perspectives
Janet Sultana, Ugo Moretti, Antonio Addis, et al.
Drug Safety (2018) Vol. 42, Iss. 5, pp. 683-687
Closed Access | Times Cited: 7
Does spontaneous adverse drug reactions’ reporting differ between different reporters? A study in Toulouse Pharmacovigilance Centre
Carole Nicol, Florence Moulis, Emmanuelle Bondon‐Guitton, et al.
Therapies (2019) Vol. 74, Iss. 5, pp. 521-525
Closed Access | Times Cited: 7
Motives to Report Adverse Drug Reactions to the National Agency: A Survey Study among Healthcare Professionals and Patients in Croatia, The Netherlands, and the UK
Sieta T. de Vries, Petra Denig, Adriana Andrić, et al.
Drug Safety (2021) Vol. 44, Iss. 10, pp. 1073-1083
Open Access | Times Cited: 6
Developing a Mobile Health Application to Communicate Adverse Drug Reactions – Preconditions, Assessment of Possible Functionalities and Barriers for Patients and Their General Practitioners
Ines Wakob, Gordian Lukas Schmid, Ingo Nöhring, et al.
Journal of Multidisciplinary Healthcare (2022) Vol. Volume 15, pp. 1445-1455
Open Access | Times Cited: 4
A Mobile App Leveraging Citizenship Engagement to Perform Anonymized Longitudinal Studies in the Context of COVID-19 Adverse Drug Reaction Monitoring: Development and Usability Study
Marzia Di Filippo, Alessandro Avellone, Michael Belingheri, et al.
JMIR Human Factors (2022) Vol. 9, Iss. 4, pp. e38701-e38701
Open Access | Times Cited: 4
An Awareness of Pharmacovigilance among Healthcare Professionals Due to an Underreporting of Adverse Drug Reactions Issue: A Systematic Review of the Current State, Obstacles, and Strategy
Risani Andalasia Putri, Zullies Ikawati, Fita Rahmawati, et al.
Current Drug Safety (2023) Vol. 19, Iss. 3, pp. 317-331
Open Access | Times Cited: 2
Evaluation of the Med Safety mobile app for reporting adverse events in Burkina Faso
Joël Ouoba, Sougrimani Haro-Lankoandé, Aminata P. Nacoulma, et al.
Drugs & Therapy Perspectives (2024) Vol. 40, Iss. 8, pp. 330-339
Open Access
Consumer views on the use of digital tools for reporting adverse drug reactions: a cross-sectional study
Mohammed Gebre Dedefo, Renly Lim, Gizat M. Kassie, et al.
International Journal of Clinical Pharmacy (2024)
Open Access
Page 1 - Next Page

Scroll to top